Back to company

EvodiaBio ApS: Financial statements 2025

CVR: 42569283

EvodiaBio ApS (CVR 42569283) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -8,437,110 and a net result of DKK -26,798,122 compared with DKK -21,106,598 the year before. Equity amounted to DKK 68,626,121. The solvency ratio was 76.8%. The company had 23 employees in the financial year.

Gross Profit
-8,437,110 kr.
Profit/Loss
-26,798,122 kr.
Equity
68,626,121 kr.
Total Assets
89,335,075 kr.
Employees
23

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025--8.4 mio.-26.8 mio.68.6 mio.23
2024--10 mio.-21.1 mio.52.4 mio.17
2023--9.9 mio.-14.1 mio.23.6 mio.10
2022--2.9 mio.-6.3 mio.37.7 mio.7

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like EvodiaBio ApS

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2025

Jarne Elleholm registered as owner of EvodiaBio ApSDec 17, 2025

As of December 17, 2025, Jarne Elleholm is registered as an owner of EvodiaBio ApS with an ownership share of 5%.

FormanBiotech Holding ApS registered as owner of EvodiaBio ApSDec 17, 2025

As of December 17, 2025, FormanBiotech Holding ApS is registered as an owner of EvodiaBio ApS with an ownership share of 5%.

STARFISH BIO ApS registered as owner of EvodiaBio ApSDec 17, 2025

As of December 17, 2025, STARFISH BIO ApS is registered as an owner of EvodiaBio ApS with an ownership share of 5%.

SDBIO ApS registered as owner of EvodiaBio ApSDec 17, 2025

As of December 17, 2025, SDBIO ApS is registered as an owner of EvodiaBio ApS with an ownership share of 5%.

Danmarks Eksport- og Investeringsfond registered as owner of EvodiaBio ApSDec 17, 2025

As of December 17, 2025, Danmarks Eksport- og Investeringsfond is registered as an owner of EvodiaBio ApS with an ownership share of 10%.

Registered as owner of EvodiaBio ApSDec 17, 2025

As of December 17, 2025, is registered as an owner of EvodiaBio ApS with an ownership share of 15%.

Kyle Bjorn Teamey joins the board of EvodiaBio ApSDec 9, 2025

As of December 9, 2025, Kyle Bjorn Teamey has joined the board of directors of EvodiaBio ApS.

Sotirios Kampranis leaves the board of EvodiaBio ApSDec 9, 2025

As of December 9, 2025, Sotirios Kampranis has left the board of directors of EvodiaBio ApS.

Lauri Johannes Reuter leaves the board of EvodiaBio ApSDec 9, 2025

As of December 9, 2025, Lauri Johannes Reuter has left the board of directors of EvodiaBio ApS.

Simon Louis Théodore Armand Dusséaux steps down as director of EvodiaBio ApSJul 31, 2025

As of July 31, 2025, Simon Louis Théodore Armand Dusséaux has stepped down as director of EvodiaBio ApS.

About EvodiaBio ApS

EvodiaBio ApS is a Danish company of the type Anpartsselskab based in Rødovre, founded in 2021. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Camilla Benedicte Kloss Fenneberg. The company's owners include Jarne Elleholm, BII Holdings A/S and FormanBiotech Holding ApS. In 2025, the company reported a gross profit of DKK -8,437,110 and a net result of DKK -26,798,122 compared with DKK -21,106,598 the year before. Equity amounted to DKK 68,626,121.

Other financial years